体外粒度测量在多大程度上能够预测体内药物递送情况？ - Suppr

Suppr

超能文献

How well do in vitro particle size measurements predict drug delivery in vivo?

作者信息

Newman S P

机构信息

Pharmaceutical Profiles Ltd., Nottingham, United Kingdom.

出版信息

J Aerosol Med. 1998;11 Suppl 1:S97-104.

PMID:10180741

Abstract

摘要

相似文献

How well do in vitro particle size measurements predict drug delivery in vivo?体外粒度测量在多大程度上能够预测体内药物递送情况？

J Aerosol Med. 1998;11 Suppl 1:S97-104.

Can in vitro particle size measurements be used to predict pulmonary deposition of aerosol from inhalers?体外粒度测量能否用于预测吸入器气雾剂的肺部沉积？

J Aerosol Med. 1998;11 Suppl 1:S43-52.

Comparisons between inhaled fine particle fractions and lung dose for nebulized aerosols.雾化气溶胶吸入细颗粒部分与肺部剂量的比较。

J Aerosol Med. 1998;11 Suppl 1:S65-72.

Discrepancy between in vitro and in vivo dose variability for a pressurized metered dose inhaler and a dry powder inhaler.定量压力气雾剂和干粉吸入器体外与体内剂量变异性之间的差异。

J Aerosol Med. 1998;11 Suppl 1:S59-64.

The current laboratory determination of "respirable mass" is not clinically relevant.目前实验室对“可吸入质量”的测定与临床无关。

J Aerosol Med. 1998;11 Suppl 1:S122-32.

Influence of realistic airflow rate on aerosol generation by nebulizers.实际气流速率对雾化器产生气溶胶的影响。

Int J Pharm. 2009 Apr 17;371(1-2):99-105. doi: 10.1016/j.ijpharm.2008.12.027. Epub 2008 Dec 27.

Aerosol drug delivery: developments in device design and clinical use.气溶胶药物递送：装置设计与临床应用的进展

Lancet. 2011 Sep 10;378(9795):981-2; author reply 982. doi: 10.1016/S0140-6736(11)61444-X.

Design and testing of aerosol delivery systems for reproducible clinical performance.用于可重复临床性能的气溶胶输送系统的设计与测试。

J Aerosol Med. 1998;11 Suppl 1:S84-8.

Nebulizer delivery of micafungin aerosols.雾化器输送米卡芬净气溶胶。

Pharmacotherapy. 2011 Jan;31(1):52-7. doi: 10.1592/phco.31.1.52.

What is a respirable dose?什么是可吸入剂量？

J Aerosol Med. 1998;11 Suppl 1:S89-96.

引用本文的文献

[Can mesh nebulizers improve prehospital aerosol therapy? An in vitro study on simulated prehospital emergency patients suffering from respiratory distress].[网状雾化器能否改善院前雾化治疗？对模拟院前呼吸窘迫急诊患者的体外研究]

Anaesthesiologie. 2022 Oct;71(10):758-766. doi: 10.1007/s00101-022-01183-y. Epub 2022 Aug 17.

Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing.开发在实验室中评估患者和护理人员如何使用吸入装置的方法：临床适当测试的必要性。

AAPS PharmSciTech. 2014 Oct;15(5):1275-91. doi: 10.1208/s12249-014-0145-4. Epub 2014 Jun 4.

Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.药物气雾剂在呼吸道中的沉积机制。

AAPS PharmSciTech. 2014 Jun;15(3):630-40. doi: 10.1208/s12249-014-0092-0. Epub 2014 Feb 22.

In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.级联撞击器测试与吸入器性能的体外和体内研究进展：综述

AAPS PharmSciTech. 2007 Dec 21;8(4):E110. doi: 10.1208/pt0804110.

The Diskus: a review of its position among dry powder inhaler devices.都保：干粉吸入装置中的地位综述

Int J Clin Pract. 2007 Jun;61(6):1022-36. doi: 10.1111/j.1742-1241.2007.01382.x.

Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.由喷雾干燥的布地奈德微晶分散在HFA-134a中组成的混悬型定量吸入气雾剂制剂的特性研究

Pharm Res. 2004 Sep;21(9):1607-14. doi: 10.1023/b:pham.0000041455.13980.f1.

Deposition and effects of inhaled corticosteroids.吸入性糖皮质激素的沉积与作用

Clin Pharmacokinet. 2003;42(6):529-44. doi: 10.2165/00003088-200342060-00003.

Influence of fluoxetine on olanzapine pharmacokinetics.氟西汀对奥氮平药代动力学的影响。

AAPS PharmSci. 2002;4(2):E11. doi: 10.1208/ps040211.

In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler.来自定量压力吸入器的中空多孔颗粒在体内的肺部沉积。

Pharm Res. 2002 Mar;19(3):258-64. doi: 10.1023/a:1014482615914.

Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?肺部沉积数据能否作为吸入性哮喘药物临床反应的替代指标？

Br J Clin Pharmacol. 2000 Jun;49(6):529-37. doi: 10.1046/j.1365-2125.2000.00106.x.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验